120 related articles for article (PubMed ID: 9128420)
1. [A case report of typical scleroderma accompanied with serum abnormalities characteristic of SLE during the course].
Nishiyama S; Kakihara H; Miyawaki S
Ryumachi; 1997 Feb; 37(1):24-9. PubMed ID: 9128420
[TBL] [Abstract][Full Text] [Related]
2. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
3. [A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment].
Wakasugi M; Sato T; Maruyama Y; Ueno M; Arakawa M
Ryumachi; 1996 Jun; 36(3):545-50. PubMed ID: 8779791
[TBL] [Abstract][Full Text] [Related]
4. Is Kikuchi-Fujimoto disease a manifestation of systemic lupus erythematosus?
Rao GS; Vohra D; Kuruvilla M
Int J Dermatol; 2006 Apr; 45(4):454-6. PubMed ID: 16650177
[TBL] [Abstract][Full Text] [Related]
5. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
[TBL] [Abstract][Full Text] [Related]
6. [A case of systemic lupus erythematosus presenting with myelofibrosis as a cause of pancytopenia].
Fukuya H; Hirose W; Masuda T; Kawai T; Watanabe K; Kawagoe M
Ryumachi; 1994 Aug; 34(4):773-8. PubMed ID: 7974029
[TBL] [Abstract][Full Text] [Related]
7. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
8. [Systemic lupus erythematosus presenting chronic relapsing polyneuropathy as the first manifestation without auto-antibodies].
Sotomatsu A; Tanaka M; Yamaguchi H; Okamoto K; Hirai S
Rinsho Shinkeigaku; 1990 Sep; 30(9):985-8. PubMed ID: 2265510
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
Voss A; Nielsen EH; Svehag SE; Junker P
J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
[TBL] [Abstract][Full Text] [Related]
11. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
13. [Systemic lupus erythematosus and antiphospholipid antibody syndrome in a patient with congenital ichthyosiform erythroderma].
Nishiyama S; Miyawaki S
Ryumachi; 1995 Aug; 35(4):688-92. PubMed ID: 7482067
[TBL] [Abstract][Full Text] [Related]
14. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
[TBL] [Abstract][Full Text] [Related]
16. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
18. [A case of progressive systemic sclerosis associated with mutilans-type arthropathy and suspected Felty's syndrome].
Sato T; Ozawa T; Kikuchi M; Nakano M; Gejyo F; Hanyu T; Takahashi C; Nakazono K; Murasawa A; Arakawa M
Ryumachi; 1990 Feb; 30(1):53-9. PubMed ID: 2377941
[TBL] [Abstract][Full Text] [Related]
19. [What are IgG antibodies to single-stranded DNA measured by enzyme immunoassay--re-evaluation of their clinical significance].
Miyawaki S; Genko J; Kawamura M
Ryumachi; 1995 Dec; 35(6):889-98. PubMed ID: 8720266
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
